Catheter Precision, Inc. (VTAK) 10-Year Financial Performance & Capital Metrics

VTAK • • Industrial / General

HealthcareMedical DevicesCardiovascular DevicesCardiac Ablation & Electrophysiology

AboutCatheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.Show more

Revenue $420K -5.0%
EBITDA -$9M +88.0%
Net Income -$17M +76.4%
EPS (Diluted) -6.68 +48.6%
Gross Margin 90% -3.4%
EBITDA Margin -2174.76% +87.4%
Operating Margin -2676.9% +84.9%
Net Margin -3962.62% +75.2%
ROE -101.02% +78.2%
ROIC -58.82% +94.3%
Debt/Equity 0.15 +766.4%
Interest Coverage -123.55

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 40.6% through buybacks
✓Trading at only 0.6x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 9 (bottom 9%)
✗Sales declining 43.4% over 5 years
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-43.35%

3Y167.27%

TTM82.96%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-48.77%

EPS CAGR

10Y-

5Y-

3Y-

TTM52.83%

ROCE

10Y Avg-172.81%

5Y Avg-185.72%

3Y Avg-224.83%

Latest-41.68%

Peer Comparison

Cardiac Ablation & Electrophysiology

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
BSXBoston Scientific Corporation	139.56B	94.14	75.31	17.61%	13.53%	11.04%	1.9%	0.51
MDTMedtronic plc	123.61B	96.42	26.71	3.62%	13.71%	9.75%	4.19%	0.59
ITGRInteger Holdings Corporation	2.9B	82.74	24.34	10.35%	4.75%	4.98%	3.44%	0.68
ADGMAdagio Medical Holdings, Inc.	18.68M	0.88	-0.25	-10.33%	-199.86%	-270%		0.82
VTAKCatheter Precision, Inc.	3.42M	2.05	-0.31	-4.98%	-23.81%	-269.53%		0.15

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	5.98M	5.87M	6.26M	7.2M	259K	22K	14K	442K	420K
Revenue Growth %	-	-0.02%	0.07%	0.15%	-0.96%	-0.92%	-0.36%	30.57%	-0.05%
Cost of Goods Sold+	3.14M	4.17M	4.21M	8.85M	2.17M	1.56M	161K	30K	42K
COGS % of Revenue	0.53%	0.71%	0.67%	1.23%	8.39%	70.91%	11.5%	0.07%	0.1%
Gross Profit+	2.84M	1.71M	2.05M	-1.65M	-1.91M	-1.54M	-147K	412K	378K
Gross Margin %	0.47%	0.29%	0.33%	-0.23%	-7.39%	-69.91%	-10.5%	0.93%	0.9%
Gross Profit Growth %	-	-0.4%	0.2%	-1.8%	-0.16%	0.2%	0.9%	3.8%	-0.08%
Operating Expenses+	7.04M	19.46M	33.21M	56.08M	33.49M	27.73M	26.81M	78.53M	11.62M
OpEx % of Revenue	1.18%	3.32%	5.31%	7.79%	129.3%	1260.36%	1915.29%	177.67%	27.67%
Selling, General & Admin	5.32M	14.95M	30.43M	51.55M	24.53M	15.47M	16.25M	17.12M	11.35M
SG&A % of Revenue	0.89%	2.55%	4.86%	7.16%	94.72%	703.41%	1160.71%	38.74%	27.02%
Research & Development	1.72M	4.52M	2.78M	4.53M	8.96M	12.25M	6.39M	475K	272K
R&D % of Revenue	0.29%	0.77%	0.44%	0.63%	34.58%	556.95%	456.57%	1.07%	0.65%
Other Operating Expenses	0	0	0	0	0	0	4.17M	60.93M	0
Operating Income+	-4.2M	-17.76M	-31.16M	-57.73M	-35.4M	-29.27M	-26.96M	-78.12M	-11.24M
Operating Margin %	-0.7%	-3.03%	-4.98%	-8.02%	-136.68%	-1330.27%	-1925.79%	-176.74%	-26.77%
Operating Income Growth %	-	-3.23%	-0.75%	-0.85%	0.39%	0.17%	0.08%	-1.9%	0.86%
EBITDA+	-4.1M	-17.54M	-30.54M	-55.98M	-33.04M	-27.87M	-26.54M	-76.04M	-9.13M
EBITDA Margin %	-0.69%	-2.99%	-4.88%	-7.78%	-127.55%	-1266.64%	-1895.71%	-172.05%	-21.75%
EBITDA Growth %	-	-3.28%	-0.74%	-0.83%	0.41%	0.16%	0.05%	-1.87%	0.88%
D&A (Non-Cash Add-back)	95K	218K	624K	1.75M	2.37M	1.4M	421K	2.08M	2.11M
EBIT	-4.2M	-17.76M	-30.81M	-56.69M	-35.4M	-27.25M	-22.79M	-17.18M	-13.41M
Net Interest Income+	-3K	-4K	338K	788K	21K	-10K	0	347K	-10K
Interest Income	0	0	352K	1.04M	129K	0	0	347K	81K
Interest Expense	3K	4K	14K	250K	108K	10K	0	0	91K
Other Income/Expense	-3K	-4K	338K	788K	88K	2.01M	99K	7.55M	-2.26M
Pretax Income+	-4.2M	-17.76M	-30.82M	-56.94M	-35.31M	-27.26M	-26.86M	-70.57M	-13.5M
Pretax Margin %	-0.7%	-3.03%	-4.93%	-7.91%	-136.34%	-1238.95%	-1918.71%	-159.67%	-32.15%
Income Tax+	1K	1K	10K	15K	7K	4K	3K	0	3.14M
Effective Tax Rate %	1%	1%	1%	1%	1.02%	0.92%	1%	1%	1.23%
Net Income+	-4.2M	-17.77M	-30.83M	-56.96M	-36.05M	-25.07M	-26.86M	-70.57M	-16.64M
Net Margin %	-0.7%	-3.03%	-4.93%	-7.91%	-139.17%	-1139.55%	-1918.93%	-159.67%	-39.63%
Net Income Growth %	-	-3.23%	-0.74%	-0.85%	0.37%	0.3%	-0.07%	-1.63%	0.76%
Net Income (Continuing)	-4.2M	-17.77M	-30.83M	-56.96M	-35.32M	-27.26M	-26.86M	-70.57M	-16.64M
Discontinued Operations	0	0	0	0	-725K	2.19M	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-433.96	-1834.66	-4175.51	-5416.22	-1060.77	-248.22	-25.98	-12.99	-6.68
EPS Growth %	-	-3.23%	-1.28%	-0.3%	0.8%	0.77%	0.9%	0.5%	0.49%
EPS (Basic)	-433.96	-1834.66	-4175.51	-5416.22	-1060.77	-248.22	-25.98	-12.99	-6.68
Diluted Shares Outstanding	9.68K	9.68K	7.38K	10.52K	33.98K	101K	1.03M	5.5M	3.26M
Basic Shares Outstanding	9.68K	9.68K	7.38K	10.52K	33.98K	101K	1.03M	5.5M	3.26M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	5.31M	10.04M	69.23M	36M	27.62M	17.09M	16.84M	4.16M	3.29M
Cash & Short-Term Investments	3.92M	8.24M	64.31M	30.58M	23.91M	15.04M	15.86M	3.56M	2.87M
Cash Only	3.92M	8.24M	64.31M	14.58M	23.91M	15.04M	15.86M	3.56M	2.87M
Short-Term Investments	0	0	0	15.99M	0	0	0	0	0
Accounts Receivable	393K	517K	1.32M	786K	24K	21K	0	137K	70K
Days Sales Outstanding	24	32.15	77	39.85	33.82	348.41	-	113.13	60.83
Inventory	870K	1.2M	2.1M	2.78M	877K	986K	0	44K	33K
Days Inventory Outstanding	101.19	104.81	181.98	114.53	147.38	230.7	-	535.33	286.79
Other Current Assets	0	0	0	0	1.71M	0	977K	415K	316K
Total Non-Current Assets+	534K	1.23M	4.8M	8.08M	5.82M	3.96M	0	26.57M	24.48M
Property, Plant & Equipment	506K	1.16M	4.76M	7.88M	5.7M	3.92M	0	249K	196K
Fixed Asset Turnover	11.81x	5.06x	1.32x	0.91x	0.05x	0.01x	-	1.78x	2.14x
Goodwill	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	26.32M	24.27M
Long-Term Investments	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	28K	68K	45K	196K	123K	36K	0	8K	8K
Total Assets+	5.84M	11.27M	74.03M	44.08M	33.44M	21.04M	16.84M	30.74M	27.77M
Asset Turnover	1.02x	0.52x	0.08x	0.16x	0.01x	0.00x	0.00x	0.01x	0.02x
Asset Growth %	-	0.93%	5.57%	-0.4%	-0.24%	-0.37%	-0.2%	0.83%	-0.1%
Total Current Liabilities+	2.71M	2.63M	5.95M	6.81M	7.76M	5.39M	7.58M	2.47M	2.08M
Accounts Payable	473K	426K	1.13M	1.53M	471K	988K	92K	464K	230K
Days Payables Outstanding	55.02	37.33	97.63	63.18	79.15	231.17	208.57	5.65K	2K
Short-Term Debt	42K	44K	293K	293K	686K	0	0	184K	177K
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	0	0	0
Other Current Liabilities	297K	213K	1.07M	1.16M	1.97M	2.12M	369K	43K	67K
Current Ratio	1.96x	3.81x	11.64x	5.28x	3.56x	3.17x	2.22x	1.68x	1.58x
Quick Ratio	1.64x	3.36x	11.28x	4.88x	3.45x	2.99x	2.22x	1.67x	1.56x
Cash Conversion Cycle	70.18	99.63	161.35	91.2	102.05	347.94	-	-5K	-1.65K
Total Non-Current Liabilities+	3.51M	16.25M	1.38M	4.12M	4.53M	1.98M	0	7.07M	13.93M
Long-Term Debt	65K	19K	557K	265K	1.58M	0	0	0	1.5M
Capital Lease Obligations	0	-15.38M	0	2.62M	2.26M	1.98M	0	97K	13K
Deferred Tax Liabilities	0	15.38M	0	0	0	0	0	0	3.14M
Other Non-Current Liabilities	2.61M	81K	56K	0	0	0	0	6.97M	9.27M
Total Liabilities	6.22M	18.88M	7.33M	10.93M	12.29M	7.37M	7.58M	9.54M	16.01M
Total Debt+	107K	63K	850K	3.5M	4.88M	2.26M	0	372K	1.79M
Net Debt	-3.81M	-8.17M	-63.47M	-11.09M	-19.02M	-12.78M	-15.86M	-3.19M	-1.08M
Debt / Equity	-	-	0.01x	0.11x	0.23x	0.17x	-	0.02x	0.15x
Debt / EBITDA	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-
Interest Coverage	-1399.33x	-4440.00x	-2225.71x	-230.92x	-327.79x	-2926.60x	-	-	-123.55x
Total Equity+	-380K	-7.62M	66.7M	33.15M	21.15M	13.67M	9.26M	21.19M	11.76M
Equity Growth %	-	-19.04%	9.76%	-0.5%	-0.36%	-0.35%	-0.32%	1.29%	-0.45%
Book Value per Share	-39.24	-786.43	9033.72	3152.34	622.34	135.38	8.96	3.86	3.60
Total Shareholders' Equity	-380K	-7.62M	66.7M	33.15M	21.15M	13.67M	9.26M	21.19M	11.76M
Common Stock	1K	1K	1K	1K	7K	8K	0	0	0
Retained Earnings	-11.62M	-29.39M	-60.22M	-117.16M	-153.2M	-178.27M	-205.14M	-275.71M	-292.35M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-589K	-775K	-1.31M	26K	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.89M	-5.52M	-18.51M	-33.17M	-28.3M	-27.63M	-22.57M	-20.62M	-9.27M
Operating CF Margin %	-0.32%	-0.94%	-2.96%	-4.61%	-109.28%	-1255.68%	-1612%	-46.65%	-22.07%
Operating CF Growth %	-	-1.93%	-2.35%	-0.79%	0.15%	0.02%	0.18%	0.09%	0.55%
Net Income	-4.2M	-17.77M	-30.83M	-56.96M	-36.05M	-25.07M	-26.86M	-70.57M	-16.64M
Depreciation & Amortization	95K	218K	624K	1.75M	2.37M	1.56M	421K	2.08M	2.11M
Stock-Based Compensation	2.3M	12.71M	14.73M	23.54M	4.08M	2.24M	447K	1.22M	54K
Deferred Taxes	12K	53K	0	0	0	0	0	0	3.14M
Other Non-Cash Items	54K	153K	255K	406K	279K	-6M	2.88M	53.73M	2.24M
Working Capital Changes	-133K	-835K	-3.28M	-1.92M	1.01M	-358K	547K	-7.07M	-171K
Change in Receivables	-161K	-124K	-1.06M	251K	368K	42K	0	-66K	67K
Change in Inventory	-181K	-644K	-3.87M	-2.19M	352K	-197K	-14K	8K	-8K
Change in Payables	124K	-47K	699K	407K	-961K	627K	-879K	-550K	-234K
Cash from Investing+	-210K	-547K	-582K	-16.03M	15.93M	3.8M	21K	-61K	-67K
Capital Expenditures	-210K	-547K	-582K	-268K	-67K	-265K	-17K	-76K	-67K
CapEx % of Revenue	0.04%	0.09%	0.09%	0.04%	0.26%	12.05%	1.21%	0.17%	0.16%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	4.07M	38K	0	0
Cash from Financing+	5.37M	10.39M	75.17M	-526K	21.69M	14.96M	23.36M	8.39M	8.65M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	0	0	-3.56M	-225K	99K	-301K	4.46M	505K	1.19M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.1M	-6.07M	-19.09M	-33.44M	-28.37M	-27.89M	-22.59M	-20.7M	-9.34M
FCF Margin %	-0.35%	-1.03%	-3.05%	-4.65%	-109.54%	-1267.73%	-1613.21%	-46.82%	-22.23%
FCF Growth %	-	-1.9%	-2.14%	-0.75%	0.15%	0.02%	0.19%	0.08%	0.55%
FCF per Share	-216.46	-626.87	-2585.32	-3180.01	-834.93	-276.14	-21.84	-3.77	-2.86
FCF Conversion (FCF/Net Income)	0.45x	0.31x	0.60x	0.58x	0.79x	1.10x	0.84x	0.29x	0.56x
Interest Paid	3K	4K	11K	49K	28K	2K	0	204K	31K
Taxes Paid	1K	1K	5K	30K	0	2K	3K	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-104.36%	-114.08%	-132.77%	-144%	-234.29%	-463.48%	-101.02%
Return on Invested Capital (ROIC)	-	-	-721.3%	-342.25%	-219.54%	-1454.57%	-	-1027.79%	-58.82%
Gross Margin	47.49%	29.05%	32.78%	-22.93%	-738.61%	-6990.91%	-1050%	93.21%	90%
Net Margin	-70.31%	-302.64%	-492.76%	-791.18%	-13916.99%	-113954.55%	-191892.86%	-15966.52%	-3962.62%
Debt / Equity	-	-	0.01x	0.11x	0.23x	0.17x	-	0.02x	0.15x
Interest Coverage	-1399.33x	-4440.00x	-2225.71x	-230.92x	-327.79x	-2926.60x	-	-	-123.55x
FCF Conversion	0.45x	0.31x	0.60x	0.58x	0.79x	1.10x	0.84x	0.29x	0.56x
Revenue Growth	-	-1.77%	6.59%	15.06%	-96.4%	-91.51%	-36.36%	3057.14%	-4.98%

Revenue by Segment

	2024
Product	420K
Product Growth	-

Revenue by Geography

	2024
UNITED STATES	278K
UNITED STATES Growth	-
Europe	142K
Europe Growth	-

Frequently Asked Questions

Growth & Financials

Catheter Precision, Inc. (VTAK) reported $0.7M in revenue for fiscal year 2024. This represents a 88% decrease from $6.0M in 2016.

Catheter Precision, Inc. (VTAK) saw revenue decline by 5.0% over the past year.

Catheter Precision, Inc. (VTAK) reported a net loss of $17.4M for fiscal year 2024.

Dividend & Returns

Catheter Precision, Inc. (VTAK) has a return on equity (ROE) of -101.0%. Negative ROE indicates the company is unprofitable.

Catheter Precision, Inc. (VTAK) had negative free cash flow of $9.7M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Catheter Precision, Inc. (VTAK) 10-Year Financial Performance & Capital Metrics

VTAK • • Industrial / General

HealthcareMedical DevicesCardiovascular DevicesCardiac Ablation & Electrophysiology

Revenue $420K -5.0%
EBITDA -$9M +88.0%
Net Income -$17M +76.4%
EPS (Diluted) -6.68 +48.6%
Gross Margin 90% -3.4%
EBITDA Margin -2174.76% +87.4%
Operating Margin -2676.9% +84.9%
Net Margin -3962.62% +75.2%
ROE -101.02% +78.2%
ROIC -58.82% +94.3%
Debt/Equity 0.15 +766.4%
Interest Coverage -123.55

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 40.6% through buybacks
✓Trading at only 0.6x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 9 (bottom 9%)
✗Sales declining 43.4% over 5 years
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-43.35%

3Y167.27%

TTM82.96%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-48.77%

EPS CAGR

10Y-

5Y-

3Y-

TTM52.83%

ROCE

10Y Avg-172.81%

5Y Avg-185.72%

3Y Avg-224.83%

Latest-41.68%

Peer Comparison

Cardiac Ablation & Electrophysiology

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
BSXBoston Scientific Corporation	139.56B	94.14	75.31	17.61%	13.53%	11.04%	1.9%	0.51
MDTMedtronic plc	123.61B	96.42	26.71	3.62%	13.71%	9.75%	4.19%	0.59
ITGRInteger Holdings Corporation	2.9B	82.74	24.34	10.35%	4.75%	4.98%	3.44%	0.68
ADGMAdagio Medical Holdings, Inc.	18.68M	0.88	-0.25	-10.33%	-199.86%	-270%		0.82
VTAKCatheter Precision, Inc.	3.42M	2.05	-0.31	-4.98%	-23.81%	-269.53%		0.15

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	5.98M	5.87M	6.26M	7.2M	259K	22K	14K	442K	420K
Revenue Growth %	-	-0.02%	0.07%	0.15%	-0.96%	-0.92%	-0.36%	30.57%	-0.05%
Cost of Goods Sold+	3.14M	4.17M	4.21M	8.85M	2.17M	1.56M	161K	30K	42K
COGS % of Revenue	0.53%	0.71%	0.67%	1.23%	8.39%	70.91%	11.5%	0.07%	0.1%
Gross Profit+	2.84M	1.71M	2.05M	-1.65M	-1.91M	-1.54M	-147K	412K	378K
Gross Margin %	0.47%	0.29%	0.33%	-0.23%	-7.39%	-69.91%	-10.5%	0.93%	0.9%
Gross Profit Growth %	-	-0.4%	0.2%	-1.8%	-0.16%	0.2%	0.9%	3.8%	-0.08%
Operating Expenses+	7.04M	19.46M	33.21M	56.08M	33.49M	27.73M	26.81M	78.53M	11.62M
OpEx % of Revenue	1.18%	3.32%	5.31%	7.79%	129.3%	1260.36%	1915.29%	177.67%	27.67%
Selling, General & Admin	5.32M	14.95M	30.43M	51.55M	24.53M	15.47M	16.25M	17.12M	11.35M
SG&A % of Revenue	0.89%	2.55%	4.86%	7.16%	94.72%	703.41%	1160.71%	38.74%	27.02%
Research & Development	1.72M	4.52M	2.78M	4.53M	8.96M	12.25M	6.39M	475K	272K
R&D % of Revenue	0.29%	0.77%	0.44%	0.63%	34.58%	556.95%	456.57%	1.07%	0.65%
Other Operating Expenses	0	0	0	0	0	0	4.17M	60.93M	0
Operating Income+	-4.2M	-17.76M	-31.16M	-57.73M	-35.4M	-29.27M	-26.96M	-78.12M	-11.24M
Operating Margin %	-0.7%	-3.03%	-4.98%	-8.02%	-136.68%	-1330.27%	-1925.79%	-176.74%	-26.77%
Operating Income Growth %	-	-3.23%	-0.75%	-0.85%	0.39%	0.17%	0.08%	-1.9%	0.86%
EBITDA+	-4.1M	-17.54M	-30.54M	-55.98M	-33.04M	-27.87M	-26.54M	-76.04M	-9.13M
EBITDA Margin %	-0.69%	-2.99%	-4.88%	-7.78%	-127.55%	-1266.64%	-1895.71%	-172.05%	-21.75%
EBITDA Growth %	-	-3.28%	-0.74%	-0.83%	0.41%	0.16%	0.05%	-1.87%	0.88%
D&A (Non-Cash Add-back)	95K	218K	624K	1.75M	2.37M	1.4M	421K	2.08M	2.11M
EBIT	-4.2M	-17.76M	-30.81M	-56.69M	-35.4M	-27.25M	-22.79M	-17.18M	-13.41M
Net Interest Income+	-3K	-4K	338K	788K	21K	-10K	0	347K	-10K
Interest Income	0	0	352K	1.04M	129K	0	0	347K	81K
Interest Expense	3K	4K	14K	250K	108K	10K	0	0	91K
Other Income/Expense	-3K	-4K	338K	788K	88K	2.01M	99K	7.55M	-2.26M
Pretax Income+	-4.2M	-17.76M	-30.82M	-56.94M	-35.31M	-27.26M	-26.86M	-70.57M	-13.5M
Pretax Margin %	-0.7%	-3.03%	-4.93%	-7.91%	-136.34%	-1238.95%	-1918.71%	-159.67%	-32.15%
Income Tax+	1K	1K	10K	15K	7K	4K	3K	0	3.14M
Effective Tax Rate %	1%	1%	1%	1%	1.02%	0.92%	1%	1%	1.23%
Net Income+	-4.2M	-17.77M	-30.83M	-56.96M	-36.05M	-25.07M	-26.86M	-70.57M	-16.64M
Net Margin %	-0.7%	-3.03%	-4.93%	-7.91%	-139.17%	-1139.55%	-1918.93%	-159.67%	-39.63%
Net Income Growth %	-	-3.23%	-0.74%	-0.85%	0.37%	0.3%	-0.07%	-1.63%	0.76%
Net Income (Continuing)	-4.2M	-17.77M	-30.83M	-56.96M	-35.32M	-27.26M	-26.86M	-70.57M	-16.64M
Discontinued Operations	0	0	0	0	-725K	2.19M	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-433.96	-1834.66	-4175.51	-5416.22	-1060.77	-248.22	-25.98	-12.99	-6.68
EPS Growth %	-	-3.23%	-1.28%	-0.3%	0.8%	0.77%	0.9%	0.5%	0.49%
EPS (Basic)	-433.96	-1834.66	-4175.51	-5416.22	-1060.77	-248.22	-25.98	-12.99	-6.68
Diluted Shares Outstanding	9.68K	9.68K	7.38K	10.52K	33.98K	101K	1.03M	5.5M	3.26M
Basic Shares Outstanding	9.68K	9.68K	7.38K	10.52K	33.98K	101K	1.03M	5.5M	3.26M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	5.31M	10.04M	69.23M	36M	27.62M	17.09M	16.84M	4.16M	3.29M
Cash & Short-Term Investments	3.92M	8.24M	64.31M	30.58M	23.91M	15.04M	15.86M	3.56M	2.87M
Cash Only	3.92M	8.24M	64.31M	14.58M	23.91M	15.04M	15.86M	3.56M	2.87M
Short-Term Investments	0	0	0	15.99M	0	0	0	0	0
Accounts Receivable	393K	517K	1.32M	786K	24K	21K	0	137K	70K
Days Sales Outstanding	24	32.15	77	39.85	33.82	348.41	-	113.13	60.83
Inventory	870K	1.2M	2.1M	2.78M	877K	986K	0	44K	33K
Days Inventory Outstanding	101.19	104.81	181.98	114.53	147.38	230.7	-	535.33	286.79
Other Current Assets	0	0	0	0	1.71M	0	977K	415K	316K
Total Non-Current Assets+	534K	1.23M	4.8M	8.08M	5.82M	3.96M	0	26.57M	24.48M
Property, Plant & Equipment	506K	1.16M	4.76M	7.88M	5.7M	3.92M	0	249K	196K
Fixed Asset Turnover	11.81x	5.06x	1.32x	0.91x	0.05x	0.01x	-	1.78x	2.14x
Goodwill	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	26.32M	24.27M
Long-Term Investments	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	28K	68K	45K	196K	123K	36K	0	8K	8K
Total Assets+	5.84M	11.27M	74.03M	44.08M	33.44M	21.04M	16.84M	30.74M	27.77M
Asset Turnover	1.02x	0.52x	0.08x	0.16x	0.01x	0.00x	0.00x	0.01x	0.02x
Asset Growth %	-	0.93%	5.57%	-0.4%	-0.24%	-0.37%	-0.2%	0.83%	-0.1%
Total Current Liabilities+	2.71M	2.63M	5.95M	6.81M	7.76M	5.39M	7.58M	2.47M	2.08M
Accounts Payable	473K	426K	1.13M	1.53M	471K	988K	92K	464K	230K
Days Payables Outstanding	55.02	37.33	97.63	63.18	79.15	231.17	208.57	5.65K	2K
Short-Term Debt	42K	44K	293K	293K	686K	0	0	184K	177K
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	0	0	0
Other Current Liabilities	297K	213K	1.07M	1.16M	1.97M	2.12M	369K	43K	67K
Current Ratio	1.96x	3.81x	11.64x	5.28x	3.56x	3.17x	2.22x	1.68x	1.58x
Quick Ratio	1.64x	3.36x	11.28x	4.88x	3.45x	2.99x	2.22x	1.67x	1.56x
Cash Conversion Cycle	70.18	99.63	161.35	91.2	102.05	347.94	-	-5K	-1.65K
Total Non-Current Liabilities+	3.51M	16.25M	1.38M	4.12M	4.53M	1.98M	0	7.07M	13.93M
Long-Term Debt	65K	19K	557K	265K	1.58M	0	0	0	1.5M
Capital Lease Obligations	0	-15.38M	0	2.62M	2.26M	1.98M	0	97K	13K
Deferred Tax Liabilities	0	15.38M	0	0	0	0	0	0	3.14M
Other Non-Current Liabilities	2.61M	81K	56K	0	0	0	0	6.97M	9.27M
Total Liabilities	6.22M	18.88M	7.33M	10.93M	12.29M	7.37M	7.58M	9.54M	16.01M
Total Debt+	107K	63K	850K	3.5M	4.88M	2.26M	0	372K	1.79M
Net Debt	-3.81M	-8.17M	-63.47M	-11.09M	-19.02M	-12.78M	-15.86M	-3.19M	-1.08M
Debt / Equity	-	-	0.01x	0.11x	0.23x	0.17x	-	0.02x	0.15x
Debt / EBITDA	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-
Interest Coverage	-1399.33x	-4440.00x	-2225.71x	-230.92x	-327.79x	-2926.60x	-	-	-123.55x
Total Equity+	-380K	-7.62M	66.7M	33.15M	21.15M	13.67M	9.26M	21.19M	11.76M
Equity Growth %	-	-19.04%	9.76%	-0.5%	-0.36%	-0.35%	-0.32%	1.29%	-0.45%
Book Value per Share	-39.24	-786.43	9033.72	3152.34	622.34	135.38	8.96	3.86	3.60
Total Shareholders' Equity	-380K	-7.62M	66.7M	33.15M	21.15M	13.67M	9.26M	21.19M	11.76M
Common Stock	1K	1K	1K	1K	7K	8K	0	0	0
Retained Earnings	-11.62M	-29.39M	-60.22M	-117.16M	-153.2M	-178.27M	-205.14M	-275.71M	-292.35M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-589K	-775K	-1.31M	26K	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.89M	-5.52M	-18.51M	-33.17M	-28.3M	-27.63M	-22.57M	-20.62M	-9.27M
Operating CF Margin %	-0.32%	-0.94%	-2.96%	-4.61%	-109.28%	-1255.68%	-1612%	-46.65%	-22.07%
Operating CF Growth %	-	-1.93%	-2.35%	-0.79%	0.15%	0.02%	0.18%	0.09%	0.55%
Net Income	-4.2M	-17.77M	-30.83M	-56.96M	-36.05M	-25.07M	-26.86M	-70.57M	-16.64M
Depreciation & Amortization	95K	218K	624K	1.75M	2.37M	1.56M	421K	2.08M	2.11M
Stock-Based Compensation	2.3M	12.71M	14.73M	23.54M	4.08M	2.24M	447K	1.22M	54K
Deferred Taxes	12K	53K	0	0	0	0	0	0	3.14M
Other Non-Cash Items	54K	153K	255K	406K	279K	-6M	2.88M	53.73M	2.24M
Working Capital Changes	-133K	-835K	-3.28M	-1.92M	1.01M	-358K	547K	-7.07M	-171K
Change in Receivables	-161K	-124K	-1.06M	251K	368K	42K	0	-66K	67K
Change in Inventory	-181K	-644K	-3.87M	-2.19M	352K	-197K	-14K	8K	-8K
Change in Payables	124K	-47K	699K	407K	-961K	627K	-879K	-550K	-234K
Cash from Investing+	-210K	-547K	-582K	-16.03M	15.93M	3.8M	21K	-61K	-67K
Capital Expenditures	-210K	-547K	-582K	-268K	-67K	-265K	-17K	-76K	-67K
CapEx % of Revenue	0.04%	0.09%	0.09%	0.04%	0.26%	12.05%	1.21%	0.17%	0.16%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	4.07M	38K	0	0
Cash from Financing+	5.37M	10.39M	75.17M	-526K	21.69M	14.96M	23.36M	8.39M	8.65M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	0	0	-3.56M	-225K	99K	-301K	4.46M	505K	1.19M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.1M	-6.07M	-19.09M	-33.44M	-28.37M	-27.89M	-22.59M	-20.7M	-9.34M
FCF Margin %	-0.35%	-1.03%	-3.05%	-4.65%	-109.54%	-1267.73%	-1613.21%	-46.82%	-22.23%
FCF Growth %	-	-1.9%	-2.14%	-0.75%	0.15%	0.02%	0.19%	0.08%	0.55%
FCF per Share	-216.46	-626.87	-2585.32	-3180.01	-834.93	-276.14	-21.84	-3.77	-2.86
FCF Conversion (FCF/Net Income)	0.45x	0.31x	0.60x	0.58x	0.79x	1.10x	0.84x	0.29x	0.56x
Interest Paid	3K	4K	11K	49K	28K	2K	0	204K	31K
Taxes Paid	1K	1K	5K	30K	0	2K	3K	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-104.36%	-114.08%	-132.77%	-144%	-234.29%	-463.48%	-101.02%
Return on Invested Capital (ROIC)	-	-	-721.3%	-342.25%	-219.54%	-1454.57%	-	-1027.79%	-58.82%
Gross Margin	47.49%	29.05%	32.78%	-22.93%	-738.61%	-6990.91%	-1050%	93.21%	90%
Net Margin	-70.31%	-302.64%	-492.76%	-791.18%	-13916.99%	-113954.55%	-191892.86%	-15966.52%	-3962.62%
Debt / Equity	-	-	0.01x	0.11x	0.23x	0.17x	-	0.02x	0.15x
Interest Coverage	-1399.33x	-4440.00x	-2225.71x	-230.92x	-327.79x	-2926.60x	-	-	-123.55x
FCF Conversion	0.45x	0.31x	0.60x	0.58x	0.79x	1.10x	0.84x	0.29x	0.56x
Revenue Growth	-	-1.77%	6.59%	15.06%	-96.4%	-91.51%	-36.36%	3057.14%	-4.98%

Revenue by Segment

	2024
Product	420K
Product Growth	-

Revenue by Geography

	2024
UNITED STATES	278K
UNITED STATES Growth	-
Europe	142K
Europe Growth	-

Frequently Asked Questions

Growth & Financials

Catheter Precision, Inc. (VTAK) reported $0.7M in revenue for fiscal year 2024. This represents a 88% decrease from $6.0M in 2016.

Catheter Precision, Inc. (VTAK) saw revenue decline by 5.0% over the past year.

Catheter Precision, Inc. (VTAK) reported a net loss of $17.4M for fiscal year 2024.

Dividend & Returns

Catheter Precision, Inc. (VTAK) has a return on equity (ROE) of -101.0%. Negative ROE indicates the company is unprofitable.

Catheter Precision, Inc. (VTAK) had negative free cash flow of $9.7M in fiscal year 2024, likely due to heavy capital investments.